02.18.2020 | Category, Uncategorized
Since FDA’s announcement in 2019, there was a lot of confusion over breast implant associated anapestic large cell lymphoma (BIA-ALCL) but the initial panic appears to subsided now. Here are what we know about the condition.
BIA-ALCL is a rare and treatable type of T-cell lymphoma that can develop around breast implants. It is not a cancer of the breast tissue itself.
The lag time between current implant insertion to diagnosis of BIA-ALCL has been from 0.8-27 years, with an average of 9.75 years.
No cases of BIA-ALCL have been reported with patients who have only had smooth im...